Related references
Note: Only part of the references are listed.Non-coding RNAs and potential therapeutic targeting in cancer
Shusuke Toden et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
The potential of long noncoding RNAs for precision medicine in human cancer
Mingming Wu et al.
CANCER LETTERS (2021)
Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling
Qiang Zhou et al.
JOURNAL OF DRUG TARGETING (2020)
Positive feedback loop SP1/MIR17HG/miR-130a-3p promotes osteosarcoma proliferation and cisplatin resistance
Yibin Meng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma
Yuhang Hu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics
Wanrong Yi et al.
ACTA PHARMACEUTICA SINICA B (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
PLK1 Knockdown Inhibits Cell Proliferation and Cell Apoptosis, and PLK1 Is Negatively Regulated by miR-4779 in Osteosarcoma Cells
Jiajun Zhu et al.
DNA AND CELL BIOLOGY (2020)
Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
Gaofeng Liang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression
Peng Shen et al.
CELL DEATH & DISEASE (2020)
Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma
Xingxing Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis
Shengjie Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2
Ji-Feng Wen et al.
CANCER BIOMARKERS (2020)
MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
Babak Otoukesh et al.
CANCER CELL INTERNATIONAL (2020)
CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway (vol 56, pg 313, 2020)
Xuelian Gong et al.
JOURNAL OF MOLECULAR HISTOLOGY (2020)
TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma
Zenghui Gu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis
Dong Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-kappa B pathway
Yuming Wang et al.
LIFE SCIENCES (2020)
CircRNAs in anticancer drug resistance: recent advances and future potential
Tianwei Xu et al.
MOLECULAR CANCER (2020)
The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential
Gouri Pandya et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells
Mohammadreza Bazavar et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells
S. Gao et al.
NEOPLASMA (2020)
Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells
Zhu Kun-Peng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
Ruiling Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro
Guowei Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
The TGF-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells
Tian Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling
Tongzhou Hu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A
Wen-chao Yu et al.
BIOSCIENCE REPORTS (2019)
The biogenesis, biology and characterization of circular RNAs
Lasse S. Kristensen et al.
NATURE REVIEWS GENETICS (2019)
MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2
Wang Haiyan et al.
JOURNAL OF BONE ONCOLOGY (2019)
SNHG16 promotes osteosarcoma progression and enhances cisplatin resistance by sponging miR-16 to upregulate ATG4B expression
Yu Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Upregulation of circular RNA circ_0000502 predicts unfavorable prognosis in osteosarcoma and facilitates cell progression via sponging miR-1238
Hongfei Qi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAAT/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p
Lei Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway
Ze-Yu Sun et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells
Yi Cheng et al.
ONCOTARGETS AND THERAPY (2019)
Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy
Tomaz Makovec
RADIOLOGY AND ONCOLOGY (2019)
miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1
Haibin Yan et al.
ANTI-CANCER DRUGS (2018)
Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis
Zhe Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin
Qi Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis
Binghua Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Knockdown of the oncogene lncRNA NEAT1 restores the availability of miR-34c and improves the sensitivity to cisplatin in osteosarcoma
Yuliang Hu et al.
BIOSCIENCE REPORTS (2018)
miRNA-20a upregulates TAK1 and increases proliferation in osteosarcoma cells
Guangke Yuan et al.
FUTURE ONCOLOGY (2018)
Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1
Zhu Kun-Peng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing
Zhu Kun-Peng et al.
EPIGENOMICS (2018)
Non-coding RNA networks in cancer
Eleni Anastasiadou et al.
NATURE REVIEWS CANCER (2018)
miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo
Zhenfeng Duan et al.
MOLECULAR ONCOLOGY (2017)
Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents
Alessandro De Vita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis
Changliang Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer
Hongzhe Li et al.
MOLECULAR CANCER (2017)
miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin
Shu-Nan Wang et al.
MOLECULAR THERAPY (2017)
Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy
Zhengguang Wang et al.
ONCOTARGET (2017)
MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2
Qiang Xiao et al.
ONCOTARGET (2017)
LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1
Zhu Kun-Peng et al.
ONCOTARGET (2017)
ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity
Lu Zhang et al.
NEOPLASIA (2017)
MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2
Yang Liu et al.
SCIENTIFIC REPORTS (2017)
被撤回的出版物: miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells (Retracted article. See vol. 160, 2023)
Wei Cai et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
miR-214 modulates cisplatin sensitivity of osteosarcoma cells through regulation of anaerobic glycolysis
Y-D. Song et al.
CELLULAR AND MOLECULAR BIOLOGY (2017)
MicroRNA-340-5p modulates cisplatin resistance by targeting LPAAT beta in osteosarcoma
L. Song et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2017)
Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2
Chun-Lin Zhang et al.
CANCER LETTERS (2017)
The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene
Youguang Pu et al.
BMC CANCER (2017)
TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma
Zaijun Lin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3
Enjie Xu et al.
ONCOLOGY REPORTS (2016)
MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy
Ruida Xu et al.
ONCOLOGY REPORTS (2016)
A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma
Chun-Lin Zhang et al.
TUMOR BIOLOGY (2016)
Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression
Yan Zhou et al.
ACTA PHARMACOLOGICA SINICA (2016)
miR-140-5p attenuates chemotherapeutic drug-induced cell death by regulating autophagy through inositol 1,4,5-trisphosphate kinase 2 (IP3k2) in human osteosarcoma cells
Renxiong Wei et al.
BIOSCIENCE REPORTS (2016)
MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene
Youguang Pu et al.
CANCER CELL INTERNATIONAL (2016)
Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis
Yuan Wang et al.
CANCER LETTERS (2016)
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells
Riccardo Di Fiore et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
Overexpression of miR-422a inhibits cell proliferation and invasion, and enhances chemosensitivity in osteosarcoma cells
Mingjiang Liu et al.
ONCOLOGY REPORTS (2016)
MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR
Yang Liu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2016)
MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells
Yusheng Li et al.
ONCOLOGY LETTERS (2016)
Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma
Chusong Zhou et al.
CELLULAR ONCOLOGY (2016)
miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors
Camille Jacques et al.
ONCOTARGET (2016)
MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line
W. Ziyan et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2016)
MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma
Yangbai Sun et al.
SCIENTIFIC REPORTS (2016)
MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1
Yuanmin Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
Xue-jun Shao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma
Jiahui Zhou et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Regulatory role of microRNA184 in osteosarcoma cells
G. R. Yin et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
Michael S. Isakoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1
Meng Xu et al.
MOLECULAR THERAPY (2015)
Quercetin Enhances Cisplatin Sensitivity of Human Osteosarcoma Cells by Modulating microRNA-217-KRAS Axis
Xian Zhang et al.
MOLECULES AND CELLS (2015)
MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate
Liangdong Jiang et al.
ONCOLOGY LETTERS (2015)
CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
Yan Gao et al.
SCIENTIFIC REPORTS (2015)
MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells
Riccardo Di Fiore et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
Yong Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
MiR-34c inhibits osteosarcoma metastasis and chemoresistance
Meng Xu et al.
MEDICAL ONCOLOGY (2014)
p53-Dependent Activation of microRNA-34a in Response to Etoposide-Induced DNA Damage in Osteosarcoma Cell Lines Not Impaired by Dominant Negative p53 Expression
Chiara Novello et al.
PLOS ONE (2014)
Blocked Autophagy by miR-101 Enhances Osteosarcoma Cell Chemosensitivity In Vitro
Zhiqiang Chang et al.
SCIENTIFIC WORLD JOURNAL (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
miR-22 targets the 3' UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy
Xuefeng Li et al.
TUMOR BIOLOGY (2014)
Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate
Liangdong Jiang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
miR-155 mediates drug resistance in osteosarcoma cells via inducing autophagy
Lu Chen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma
Meng Xu et al.
ONCOTARGET (2014)
lincRNAs: Genomics, Evolution, and Mechanisms
Igor Ulitsky et al.
CELL (2013)
The Adolescent and Young Adult with Cancer: State of the Art - Bone Tumors
Nino Rainusso et al.
CURRENT ONCOLOGY REPORTS (2013)
Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response
Angelique Gougelet et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
Bo Song et al.
MOLECULAR CANCER (2010)
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
B. Song et al.
ONCOGENE (2009)
Share Paper
